Literature DB >> 21346592

Fibroblasts, myofibroblasts, and fibrosis: fact, fiction, and the future.

Heather S Duffy1.   

Abstract

Fibroblasts and their activated phenotype known as myofibroblasts are nonexcitable cells found in all organs of the body. In the heart, fibroblasts, along with the endothelial and smooth muscle cells of the blood vessels, make up approximately 30% of tissue mass. In vitro, myofibroblasts cocultured with cardiac myocytes can propagate electrical signals down cellular strands indicating that under these conditions myofibroblasts are capable of depolarizing enough to maintain electrical propagation. This has obvious implications for cardiac biology if heterocellular coupling between fibroblasts and myocytes were to occur in the intact heart either under normal conditions or during cellular stress. The purpose of this review series is to highlight the newest information on cardiac fibroblasts and myofibroblasts and to review the data on their interactions with cardiac myocytes.

Entities:  

Mesh:

Year:  2011        PMID: 21346592     DOI: 10.1097/FJC.0b013e3182155a38

Source DB:  PubMed          Journal:  J Cardiovasc Pharmacol        ISSN: 0160-2446            Impact factor:   3.105


  15 in total

1.  Functional scaffold-free 3-D cardiac microtissues: a novel model for the investigation of heart cells.

Authors:  B R Desroches; P Zhang; B-R Choi; M E King; A E Maldonado; W Li; A Rago; G Liu; N Nath; K M Hartmann; B Yang; G Koren; J R Morgan; U Mende
Journal:  Am J Physiol Heart Circ Physiol       Date:  2012-03-16       Impact factor: 4.733

Review 2.  Role of connexins and pannexins in cardiovascular physiology.

Authors:  Merlijn J Meens; Brenda R Kwak; Heather S Duffy
Journal:  Cell Mol Life Sci       Date:  2015-06-20       Impact factor: 9.261

3.  Is TGF-β1 (Transforming Growth Factor-β1) an Enabler of Myofibroblast-Cardiomyocyte Cross Talk?

Authors:  Kuljeet Kaur; José Jalife
Journal:  Circ Arrhythm Electrophysiol       Date:  2017-05

4.  Note on a possible proarrhythmic property of antiarrhythmic drugs aimed at improving gap-junction coupling.

Authors:  Aslak Tveito; Glenn Terje Lines; Mary M Maleckar
Journal:  Biophys J       Date:  2012-01-18       Impact factor: 4.033

Review 5.  Mechanisms of cardiac conduction: a history of revisions.

Authors:  Rengasayee Veeraraghavan; Robert G Gourdie; Steven Poelzing
Journal:  Am J Physiol Heart Circ Physiol       Date:  2014-01-10       Impact factor: 4.733

6.  Acute slowing of cardiac conduction in response to myofibroblast coupling to cardiomyocytes through N-cadherin.

Authors:  Susan A Thompson; Adriana Blazeski; Craig R Copeland; Daniel M Cohen; Christopher S Chen; Daniel M Reich; Leslie Tung
Journal:  J Mol Cell Cardiol       Date:  2014-01-09       Impact factor: 5.000

7.  Resveratrol suppresses the myofibroblastic phenotype and fibrosis formation in kidneys via proliferation-related signalling pathways.

Authors:  Xing Zhang; Hong Lu; Shuangshuang Xie; Cunzao Wu; Yangyang Guo; Yanyi Xiao; Shizhang Zheng; Hengyue Zhu; Yan Zhang; Yongheng Bai
Journal:  Br J Pharmacol       Date:  2019-11-28       Impact factor: 8.739

8.  Regulation of myofibroblast differentiation by miR-424 during epithelial-to-mesenchymal transition.

Authors:  Xiao Xiao; Chaoqun Huang; Chunling Zhao; Xuxu Gou; Lakmini K Senavirathna; Myron Hinsdale; Pamela Lloyd; Lin Liu
Journal:  Arch Biochem Biophys       Date:  2014-12-15       Impact factor: 4.013

Review 9.  Triggering the landslide: The tumor-promotional effects of myofibroblasts.

Authors:  Christine Mehner; Derek C Radisky
Journal:  Exp Cell Res       Date:  2013-03-22       Impact factor: 3.905

10.  Dasatinib inhibits peripapillary scleral myofibroblast differentiation.

Authors:  Amanda Chow; Liam McCrea; Elizabeth Kimball; Julie Schaub; Harry Quigley; Ian Pitha
Journal:  Exp Eye Res       Date:  2020-03-13       Impact factor: 3.467

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.